参考文献/References:
[1]Lee GH,Jin S W,Kim S J,et al.Tetrabromobisphenol A Induces MMP-9 Expression via NADPH Oxidase and the activation of ROS,MAPK,and Akt Pathways in Human Breast Cancer MCF-7 Cells[J].Toxicological Research,2019,35(1):93.[2]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA,2018,68(6):394-424.[3]Lodillinsky C,Infante E,Guichard A,et al.p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer[J].Oncogene,2016,35(3):344.[4]Robert S,Gicquel T,Bodin A,et al.Characterization of the MMP/TIMP imbalance and collagen production induced by IL-1β or TNF-α release from human hepatic stellate cells[J].PLoS One,2016,11(4):e0153118.[5]Lima AIG,Mota J,Monteiro S,et al.Legume seeds and colorectal cancer revisited:Protease inhibitors reduce MMP-9 activity and colon cancer cell migration[J].Food Chemistry,2016(197):30-38.[6]Khrenova MG,Savitsky AP,Topol IA,et al.Exploration of the zinc finger motif in controlling activity of matrix metalloproteinases[J].The Journal of Physical Chemistry B,2014,118(47):13505-13512.[7]Yan S,Wang Y,Liu P,et al.Baicalin Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension to Improve Hypoxic Cor Pulmonale by Reducing the Activity of the p38 MAPK Signaling Pathway and MMP-9[J].Evid Based Complement Alternat Med,2016(2016):2546402.[8]Pittayapruek P,Meephansan J,Prapapan O,et al.Role of matrix metalloproteinases in photoaging and photocarcinogenesis[J].International Journal of Molecular Sciences,2016,17(6):868.[9]Salem N,Kamal I,Al-Maghrabi J,et al.High expression of matrix metalloproteinases:MMP-2 and MMP-9 predicts poor survival outcome in colorectal carcinoma[J].Future Oncology,2016,12(3):323-331.[10]Vandooren J,Van den Steen PE,Opdenakker G.Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9(MMP-9):the next decade[J].Critical Reviews in Biochemistry and Molecular Biology,2013,48(3):222-272.[11]Dong H,Diao H,Zhao Y,et al.Overexpression of matrix metalloproteinase‐9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta/SMAD signalling[J].Cell Proliferation,2019,52(5):e12633.[12]Dittmer J.The role of the transcription factor Ets1 in carcinoma[J].Seminars in Cancer biology.Academic Press,2015(35):20-38.[13]Legrand AJ,Choul-Li S,Spriet C,et al.The level of Ets-1 protein is regulated by poly(ADP-ribose)polymerase-1(PARP-1)in cancer cells to prevent DNA damage[J].PLoS One,2013,8(2):e55883.[14]Nazir SU,Kumar R,Rasool I,et al.Differential expression of Ets‐1 in breast cancer among North Indian population[J].Journal of Cellular Biochemistry,2019,120(9):14552-14561.[15]Ghosh S,Basu M,Roy SS.ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3[J].Journal of Biological Chemistry,2012,287(18):15001-15015.[16]Nazir SU,Kumar R,Singh A,et al.Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor[J].Gene,2019(711):143952.[17]Massagué J.TGFβ signalling in context[J].Nature Reviews Molecular Cell Biology,2012,13(10):616.[18]Massagué J,Xi Q.TGF-β control of stem cell differentiation genes[J].FEBS Letters,2012,586(14):1953-1958.[19]Dong H,Diao H,Zhao Y,et al.Overexpression of matrix metalloproteinase‐9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta/SMAD signalling[J].Cell Proliferation,2019,52(2):e12633.[20]Yang HL,Thiyagarajan V,Shen PC,et al.Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis[J].Journal of Experimental&Clinical Cancer Research,2019,38(1):186.[21]Li C,Li F,Zhao K,et al.LFG-500 inhibits the invasion of cancer cells via down-regulation of PI3K/AKT/NF-κB signaling pathway[J].PLoS One,2014,9(3):e91332.[22]Lin Y,Bai L,Chen W,et al.The NF-κB activation pathways,emerging molecular targets for cancer prevention and therapy[J].Expert Opinion on Therapeutic Targets,2010,14(1):45-55.[23]Huang Q,Li S,Zhang L,et al.CAPE-pNO2 inhibited the growth and metastasis of triple-negative breast cancer via the EGFR/STAT3/Akt/E-cadherin signaling pathway[J].Frontiers in Oncology,2019(9):461[24]Eccles SA.The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology[J].International Journal of Developmental Biology,2011,55(7-8-9):685-696.[25]Mehner C,Hockla A,Miller E,et al.Tumor cell-produced matrix metalloproteinase 9(MMP-9)drives malignant progression and metastasis of basal-like triple negative breast cancer[J].Oncotarget,2014,5(9):2736.[26]Van’t Veer LJ,Dai H,Van De Vijver MJ,et al.Gene expression profiling predicts clinical outcome of breast cancer[J].Nature,2002,415(6871):530.[27]Kessenbrock K,Plaks V,Werb Z.Matrix metalloproteinases:regulators of the tumor microenvironment[J].Cell,2010,141(1):52-67.[28]McGowan PM,Duffy MJ.Matrix metalloproteinase expression and outcome in patients with breast cancer:analysis of a published database[J].Annals of Oncology,2008,19(9):1566-1572.[29]Roy R,Yang J,Moses MA.Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer[J].Journal of Clinical Oncology,2009,27(31):5287.[30]Kabashima A,Maehara Y,Kakeji Y,et al.Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis[J].Clinical Cancer Research,2000,6(9):3581-3584.[31]Thammineni K L,Thakur G K,Kaur N,et al.Significance of MMP-9 and VEGF-C expression in North Indian women with breast cancer diagnosis[J].Molecular and Cellular Biochemistry,2019,457(1-2):93-103.
相似文献/References:
[1]董 云.SPECT/CT 双时相99mTc- MIBI断层显像
在乳腺癌诊断中的应用[J].医学信息,2018,31(05):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
DONG Yun.Application of SPECT/CT Dual-phase 99mTc-MIBI Tomography in the Diagnosis of Breast Cancer[J].Medical Information,2018,31(13):147.[doi:10.3969/j.issn.1006-1959.2018.05.053]
[2]张 虎,张 涛,徐 芳,等.MRI在乳腺癌诊治中的研究进展[J].医学信息,2022,35(10):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
ZHANG Hu,ZHANG Tao,XU Fang,et al.Research Progress of MRI in Diagnosis and Treatment of Breast Cancer[J].Medical Information,2022,35(13):62.[doi:10.3969/j.issn.1006-1959.2022.10.015]
[3]李建辉,祝旭龙.乳腺癌的治疗管理——把好生活质量关[J].医学信息,2018,31(13):1.[doi:10.3969/j.issn.1006-1959.2018.13.001]
[4]杨玉峰,李 强,曲国红,等.乳腺癌术前巴德枪穿刺检测ER、PR的临床研究[J].医学信息,2018,31(13):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
YANG Yu-feng,LI Qiang,QU Guo-hong,et al.Clinical Study on Preoperative ER and PR Detection of Bard Gun Puncture in Breast Cancer[J].Medical Information,2018,31(13):163.[doi:10.3969/j.issn.1006-1959.2018.13.050]
[5]刘雪静,路 红,徐熠琳,等.乳腺影像与容积导航技术初步应用的临床分析[J].医学信息,2022,35(11):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
LIU Xue-jing,LU Hong,XU Yi-lin,et al.Clinical Analysis of the Preliminary Application of Breast Imaging and Volume Navigation Technology[J].Medical Information,2022,35(13):161.[doi:10.3969/j.issn.1006-1959.2022.11.043]
[6]刘在波,修文娟.背阔肌皮瓣联合假体在乳腺癌改良根治术后乳房重建中的应用[J].医学信息,2019,32(02):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
LIU Zai-bo,XIU Wen-juan.Application of Latissimus Dorsi Flap Combined with Prosthesis in Breast Reconstruction after Modified Radical Mastectomy for Breast Cancer[J].Medical Information,2019,32(13):127.[doi:10.3969/j.issn.1006-1959.2019.02.036]
[7]孟庆国,王佳雪,王斯佳.马来酸吡咯替尼对乳腺癌术后患者心脏功能的影响[J].医学信息,2019,32(02):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
MENG Qing-guo,WANG Jia-xue,WANG Si-jia.Effect of Pyrrolidine Maleate on Cardiac Function in Patients after Breast Cancer Operation[J].Medical Information,2019,32(13):152.[doi:10.3969/j.issn.1006-1959.2019.02.045]
[8]刘 曼,厉玛倩倩,徐润润,等.延续性护理对乳腺癌术后化疗患者生活质量与
健康知识水平的影响[J].医学信息,2018,31(16):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
LIU Man,LIMA Qian-qian,XU Run-run,et al.Effect of Continuous Nursing on Quality of Life and Health Knowledge of Postoperative Chemotherapy Patients with Breast Cancer[J].Medical Information,2018,31(13):178.[doi:10.3969/j.issn.1006-1959.2018.16.057]
[9]满枋霖,葛俊宏,林晓月,等.p21活化激酶在乳腺癌中的作用研究[J].医学信息,2019,32(06):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]
MAN Fang-lin,GE Jun-hong,LIN Xiao-yue,et al.The Role of p21 Activated Kinase in Breast Cancer[J].Medical Information,2019,32(13):35.[doi:10.3969/j.issn.1006-1959.2019.06.013]
[10]张天竺,宁 勇.长链非编码RNA调控乳腺癌发生发展的研究进展[J].医学信息,2019,32(12):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]
ZHANG Tian-zhu,NING Yong.Advances in Research on Long-chain Non-coding RNA Regulation of Breast Cancer Development[J].Medical Information,2019,32(13):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]
[11]杨 静,王 新.PD-L1、MMP-9、IMP3表达水平与乳腺癌病理分期、组织学分级及预后的关系研究[J].医学信息,2022,35(14):53.[doi:10.3969/j.issn.1006-1959.2022.14.011]
YANG Jing,WANG Xin.The Relationship Between PD-L1,MMP-9,IMP3 Expression Levels and Pathological Staging,Histological Grade and Prognosis of Breast Cancer[J].Medical Information,2022,35(13):53.[doi:10.3969/j.issn.1006-1959.2022.14.011]